LGND
Ligand Pharmaceuticals Inc.
$284.70
3.45%
+9.50
Notify me if price changes either direction
Buy LGND stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
5.7B
Enterprise value
5.3B
Trailing PE
28.341917
Forward PE
23.058348
PEG Ratio
0.032651978110599
Enterprise to EBITDA
39.545
Enterprise to revenue
18.104
Price to book MRQ
5.6660495
Price to sales TTM
18.882914
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
290.5M
EBITDA
94.5M
Diluted EPS TTM
9.71
Total Cash (MRQ)
1.4B
Current ratio (MRQ)
31.178
Operating Cash Flow (TTM)
131.7M
LGND trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
September 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
